An analysis of preclinical efficacy testing of antivenoms for sub-Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management
Tóm tắt
Từ khóa
Tài liệu tham khảo
RA Harrison, 2009, Snake envenoming: A disease of poverty., PLoS Negl Trop Dis., 3, e569, 10.1371/journal.pntd.0000569
DJ Williams, 2019, Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming., PLoS Negl Trop Dis., 13, e0007059, 10.1371/journal.pntd.0007059
NR Casewell, 2010, Pre-clinical assays predict Pan-African Echis viper efficacy for a species-specific antivenom., PLoS Negl Trop Dis., 4, e851, 10.1371/journal.pntd.0000851
B Ramos-Cerrillo, 2008, Characterization of a new polyvalent antivenom (Antivipmyn® Africa) against African vipers and elapids., Toxicon, 52, 881, 10.1016/j.toxicon.2008.09.002
RB Currier, 2010, Intra-specific variation in venom of the African Puff Adder (Bitis arietans): Differential expression and activity of snake venom metalloproteinases (SVMPs)., Toxicon, 55, 864, 10.1016/j.toxicon.2009.12.009
D Pla, 2019, Phylovenomics of Daboia russelii across the Indian subcontinent. Bioactivities and comparative in vivo neutralization and in vitro third-generation antivenomics of antivenoms against venoms from India, Bangladesh and Sri Lanka., J Proteomics., 207, 103443, 10.1016/j.jprot.2019.103443
NR Casewell, 2014, Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms, Proc Natl Acad Sci U S A, 111, 9205, 10.1073/pnas.1405484111
RR Senji Laxme, Beyond the ‘Big four’: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies., PLoS Negl Trop Dis., 13, e0007899, 10.1371/journal.pntd.0007899
World Health Organization (WHO). Guidelines for the production, control and regulation of snake antivenom immunoglobulins. WHO. 2018. Available: https://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en/
J Potet, 2019, Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial., PLoS Negl Trop Dis, 13, e0007551, 10.1371/journal.pntd.0007551
LE Visser, 2008, Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance, Trans R Soc Trop Med Hyg, 102, 445, 10.1016/j.trstmh.2007.11.006
E Alirol, 2015, Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?, PLoS Negl Trop Dis., 9, e0003896, 10.1371/journal.pntd.0003896
ER Bregani, 2006, Snake bites in South Chad. Comparison between three different polyvalent anti-snake venom immunotherapies., G Ital di Med Trop., 11, 25
RA Harrison, 2017, Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa., PLoS Negl Trop Dis., 11, e0005969, 10.1371/journal.pntd.0005969
D Pla, 2017, Third generation antivenomics: Pushing the limits of the in vitro preclinical assessment of antivenoms., Toxins (Basel)., 9, 6
RDG Theakston, 1983, Development of simple standard assay procedures for the characterization of snake venoms, Bull World Health Organ, 61, 949
JM Gutiérrez, 2013, Assessing the preclinical efficacy of antivenoms: From the lethality neutralization assay to antivenomics, Toxicon, 69, 168, 10.1016/j.toxicon.2012.11.016
JM Gutiérrez, 2017, Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: State-of-the-art and challenges ahead., Toxins (Basel)., 9, 1, 10.3390/toxins9050163
C Kilkenny, 2010, Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research, PLOS Biol, 8, e1000412, 10.1371/journal.pbio.1000412
N Percie du Sert, 2018, Revision of the ARRIVE guidelines: rationale and scope, BMJ Open Sci, 2, e000002, 10.1136/bmjos-2018-000002
V Leung, 2018, Arrive has not arrived: Support for the arrive (animal research: Reporting of in vivo experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia., PLoS One., 13, e0197882, 10.1371/journal.pone.0197882
S Ainsworth, 2018, The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms., Commun Biol., 1, 34, 10.1038/s42003-018-0039-1
D Petras, 2011, Snake venomics of African spitting cobras: Toxin composition and assessment of congeneric cross-reactivity of the Pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches, J Proteome Res, 10, 1266, 10.1021/pr101040f
LP Lauridsen, 2016, Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps)., J Proteomics, 136, 248, 10.1016/j.jprot.2016.02.003
A Sánchez, 2017, Expanding the neutralization scope of the EchiTAb-plus-ICP antivenom to include venoms of elapids from Southern Africa, Toxicon, 125, 59, 10.1016/j.toxicon.2016.11.259
JJ Calvete, 2016, Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics, Toxicon, 119, 280, 10.1016/j.toxicon.2016.06.022
T Tasoulis, 2017, A review and database of snake venom proteomes., Toxins (Basel)., 9, 290, 10.3390/toxins9090290
K Ratanabanangkoon, 2016, A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia., PLoS Negl Trop Dis., 10, e0004565, 10.1371/journal.pntd.0004565
C Chotwiwatthanakun, 2001, Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol, Toxicon, 39, 148700108, 10.1016/S0041-0101(01)00108-8
M Hamza, 2016, Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa., PLoS Negl Trop Dis., 10, e0004568, 10.1371/journal.pntd.0004568
V. Sánchez L, 2015, Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria, Toxicon, 106, 97, 10.1016/j.toxicon.2015.09.027
SB Abubakar, 2010, Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria., Toxicon, 55, 719, 10.1016/j.toxicon.2009.10.024
IS Abubakar, 2010, Randomised controlled double-blind non-inferiority trial of two antivenoms for Saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria., PLoS Negl Trop Dis, 4, e767, 10.1371/journal.pntd.0000767
DA Warrell, 1974, Bites by the Saw-scaled or Carpet Viper (Echis carinatus): Trial of Two Specific Antivenoms., Br Med J
DA Warrell, 1977, Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in nigeria., QJM, 46, 33
DAN Cook, 2010, Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology, Toxicon, 56, 373, 10.1016/j.toxicon.2010.04.005
GD Dzikouk, 2002, Titrage comparatif de trois sérums antivenimeux utilisés contre les serpents d’Afrique sub-saharienne., Bull la Soc Pathol Exot., 95, 144
Á Segura, 2010, Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP®) for the treatment of viper envenoming in sub-Saharan Africa., Toxicon, 55, 369, 10.1016/j.toxicon.2009.08.010
SS Seddik, 2002, Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines, J Nat Toxins, 11, 329
EE Sánchez, 2011, Neutralization of bitis parviocula (Ethiopian mountain adder) venom by the south african institute of medical research (SAIMR) antivenom., Rev Inst Med Trop Sao Paulo
G Whiteley, 2019, Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom., J Proteomics, 198, 186, 10.1016/j.jprot.2018.09.019
AG Habib, 2001, Snake bite in Nigeria., African journal of medicine and medical sciences, 30, 171
DA Warrell, 1976, Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis)., Q J Med, 45, 1
W Wüster, 2007, The phylogeny of cobras inferred from mitochondrial DNA sequences: Evolution of venom spitting and the phylogeography of the African spitting cobras (Serpentes: Elapidae: Naja nigricollis complex)., Mol Phylogenet Evol, 45, 437, 10.1016/j.ympev.2007.07.021
A Sánchez, 2015, Effect of geographical variation of Echis ocellatus, Naja nigricollis and Bitis arietans venoms on their neutralization by homologous and heterologous antivenoms, Toxicon, 108, 80, 10.1016/j.toxicon.2015.10.001
RS Blaylock, 2005, The identification and syndromic management of snakebite in South Africa., South African Family Practice., 47, 48, 10.1080/20786204.2005.10873288
AH Laustsen, 2015, Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development., J Proteomics., 119, 126, 10.1016/j.jprot.2015.02.002
J Miller, 2019, Sharing of clinical trial data and results reporting practices among large pharmaceutical companies: Cross sectional descriptive study and pilot of a tool to improve company practices, BMJ, 366
B Goldacre, 2017, Pharmaceutical companies’ policies on access to trial data, results, and methods: Audit study, BMJ, 358, j3334, 10.1136/bmj.j3334
NI Brown, 2012, Consequences of neglect: Analysis of the sub-saharan african snake antivenom market and the global context., PLoS Negl Trop Dis., 6, e1670, 10.1371/journal.pntd.0001670
CG Begley, 2015, Reproducibility in science: Improving the standard for basic and preclinical research, Circulation Research, 116, 116, 10.1161/CIRCRESAHA.114.303819
V Morais, 2010, Antivenoms: Potency or median effective dose, which to use?, Journal of Venomous Animals and Toxins Including Tropical Diseases, 16, 191, 10.1590/S1678-91992010000200002
G Bogarín, 2000, Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica, Toxicon, 38, 1429, 10.1016/S0041-0101(99)00236-6
J Slagboom, 2017, Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise, Br J Haematol, 177, 947, 10.1111/bjh.14591
C Herrera, 2018, Analgesic effect of morphine and tramadol in standard toxicity assays in mice injected with venom of the snake Bothrops asper, Toxicon, 154, 35, 10.1016/j.toxicon.2018.09.012
W Wüster, 2018, Integration of nuclear and mitochondrial gene sequences and morphology reveals unexpected diversity in the forest cobra (Naja melanoleuca) species complex in Central and West Africa (Serpentes: Elapidae)., Zootaxa, 4455, 068, 10.11646/zootaxa.4455.1.3
S Halilu, 2019, Snakebite burden in Sub-Saharan Africa: estimates from 41 countries, Toxicon, 159, 1, 10.1016/j.toxicon.2018.12.002
J Longbottom, 2018, Vulnerability to snakebite envenoming: a global mapping of hotspots, Lancet, 392, 673, 10.1016/S0140-6736(18)31224-8
DJ Williams, 2018, Clinical studies of the effectiveness and safety of antivenoms, Toxicon, 150, 1, 10.1016/j.toxicon.2018.05.001
MC Baldé, 2013, Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa., J Venom Anim Toxins Incl Trop Dis., 19
DA Warrell, 2008, Clinical toxicology of snakebite in Africa and the middle east / Arabian Peninsula., Handbook of Clinical Toxicology of Animal Venoms and Poisons
WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins
DJ Williams, 2011, Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa., J Proteomics, 74, 1735, 10.1016/j.jprot.2011.05.027
L-O Albulescu, 2020, Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite., Sci Transl Med., 12, eaay8314, 10.1126/scitranslmed.aay8314
L-O Albulescu, 2020, A therapeutic combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite., bioRxiv.
MR Lewin, 2018, Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of micrurus fulvius (eastern coral snake) venom., Toxins (Basel)., 10, 479, 10.3390/toxins10110479
MR Lewin, 2018, Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan taipan (Oxyuranus scutellatus) venom., Toxins (Basel)., 10, 380, 10.3390/toxins10100380
P Morgan, 2012, Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival, Drug Discovery Today, 17, 419, 10.1016/j.drudis.2011.12.020